Cross-Sector entity
markets is the sole category represented across all 1 tracked stories. Compass Pathways plc is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 9 original sources on average. We currently track 1 Cross-Sector story that mention Truecaller AB, all published on February 17, 2026.
1 verified story tracked
Last mentioned: Feb 17, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Compass Pathways plc is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 9 original sources on average. We currently track 1 Cross-Sector story that mention Truecaller AB, all published on February 17, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Truecaller AB. Shared-story counts are live from our verified record — not editorial picks.
The equity markets are navigating a complex landscape of 'sell-the-news' reactions and extreme biotech volatility following a series of clinical and financial updates. While Compass Pathways surged on positive trial results, Ocular Therapeutix and Genmab faced significant selling pressure despite reaching key milestones.
